1 week Ago By Defense World Staff
JPMorgan Chase & Co. lifted its stake in shares of Grand Canyon Education, Inc. (NASDAQ:LOPE – Free Report) by 5.
7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 167,206 shares of the company’s stock after acquiring an additional 9,083 shares during the quarter. JPMorgan Chase & Co.
owned 0.57% of Grand Canyon Education worth $27,388,000 at the end of the most recent reporting period. Other hedge funds have also modified their holdings of the company.
Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Grand Canyon Education in the 4th quarter valued at $27,000. Financial Life Planners acquired a new position in shares of Grand Canyon Education in the fourth quarter worth about $37,000.
Harvest Fund Management Co. Ltd purchased a new position in shares of Grand Canyon Education in the fourth quarter worth approximately $59,000. Versant Capital Management Inc raised its holdings in shares of Grand Canyon Education by 66.
0% during the fourth quarter. Versant Capital Management Inc now owns 420 shares of the company’s stock valued at $69,000 after acquiring an additional 167 shares during the period. Finally, Geneos Wealth Management Inc.
lifted its position in shares of Grand Canyon Education by 22.5% in the 4th quarter. Geneos Wealth Management Inc.
now owns 539 shares of the company’s stock valued at $88,000 after acquiring an additional 99 shares in the last quarter. 94.17% of the stock is currently owned by institutional investors and hedge funds.
Grand Canyon Education Trading Down 2.7 %LOPE opened at $162.37 on Wednesday.
The stock has a fifty day moving average price of $175.65 and a 200 day moving average price of $162.83.
Grand Canyon Education, Inc. has a 1 year low of $126.17 and a 1 year high of $192.
18. The stock has a market cap of $4.66 billion, a price-to-earnings ratio of 20.
98, a PEG ratio of 1.42 and a beta of 0.82.
Grand Canyon Education (NASDAQ:LOPE – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.
93 by $0.02. Grand Canyon Education had a return on equity of 30.
67% and a net margin of 21.90%. The business had revenue of $292.
57 million during the quarter, compared to analyst estimates of $289.62 million. As a group, sell-side analysts forecast that Grand Canyon Education, Inc.
will post 8.81 earnings per share for the current fiscal year. Analysts Set New Price TargetsSeveral analysts have issued reports on the stock.
Barrington Research boosted their target price on shares of Grand Canyon Education from $180.00 to $205.00 and gave the company an “outperform” rating in a research note on Thursday, February 20th.
BMO Capital Markets upped their price target on Grand Canyon Education from $181.00 to $202.00 and gave the company an “outperform” rating in a research report on Friday, February 21st.
Finally, StockNews.com raised Grand Canyon Education from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th.Read Our Latest Stock Report on Grand Canyon EducationGrand Canyon Education Profile (Free Report)Grand Canyon Education, Inc provides education services to colleges and universities in the United States.
It offers technology services, including learning management system, internal administration, infrastructure, and support services; academic services, such as program and curriculum, faculty and related training and development, class scheduling, and skills and simulation lab sites; and counseling services and support services comprising admission, financial aid, and field experience and other counseling services.Further ReadingFive stocks we like better than Grand Canyon EducationWhat Investors Must Know About Over-the-Counter (OTC) StocksTariff-Proof Stocks: 3 Big Bargains With Huge Upside PotentialWhat is the Hang Seng index? Qualcomm Breaks Down But RSI Signals It’s Severely OversoldHow to Invest in Biotech StocksTesla’s #1 Bull Cuts Target But Says It’s Still a Buy.
